Mutations in SEC23B were subsequently identified as the cause of congenital dyserythropoietic anemia type II (CDAII), a disorder characterized by ineffective erythropoiesis associated with multinucleated erythroblasts12, 13. This evidence concerns the gene SEC23B and congenital dyserythropoietic anemia type 2.